Clinical Decision Pathway for the Use of Fondaparinux in the Management of Acute Coronary Syndrome (ACS) in Hospitals with and Without Catheter Laboratories: An Expert Opinion from India

Clinical Decision Pathway for the Use of Fondaparinux in the Management of Acute Coronary Syndrome (ACS) in Hospitals with and Without Catheter Laboratories: An Expert Opinion from India

Abstract The current recommendations by Indian experts who are focused on the challenges in the management of patients with acute coronary syndrome (ACS) in rural areas, due to limited catheterization (CATH) lab facilities and interventional cardiologist coverage across the country, are described. 1...

Full description

Bibliographic Details
Main Authors: Saumitra Ray, Bharat Shivdasani, Jagdish Chander Mohan, V. T. Shah, Jagdish Hiremath, Rajiv Karnik, Bhupen Desai, Hemant Madan, Rajeev Garg, Johann Christopher
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-04-01
Series:Cardiology and Therapy
Subjects:
Acute coronary syndrome
Anticoagulant
Fondaparinux
Percutaneous coronary intervention
Online Access:https://doi.org/10.1007/s40119-023-00312-x

Internet

https://doi.org/10.1007/s40119-023-00312-x

Similar Items